Go Back This article was viewed 92 times

Review Article


Unforeseen consequences of cancer immunotherapy

Radhika VaishnavWakas ArslanDivyesh G. Mehta
Research Director, Vadodara Stroke Center1Scientific Director, Natureka Life Sciences, Vadodara, Gujarat, India, 2Maricopa Integrated Health Services, 3Chief, Hematology Oncology Division, Maricopa Integrated Health Services, 4Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA, 
Corresponding Author:

Divyesh G. Mehta

["Chief, Hematology Oncology Division, Maricopa Integrated Health Services","Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA"]
E-mail: Divyesh_Mehta@dmgaz.org

Corresponding Author:

Divyesh G. Mehta

["Chief, Hematology Oncology Division, Maricopa Integrated Health Services","Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA"]
E-mail: Divyesh_Mehta@dmgaz.org

DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20180469

ABSTRACT


With the increasing use of immunotherapy for various cancers, it is essential that clinicians become aware of some of the unique consequences and sude effects associated with these new treatments. Ranging from pneumonitis and colitis to Type 1 Diabetes Mellitus, immune related adverse events have been reported. Some side effects may be confused with cancer progression and thus awareness and clinical presentation of these is critical and necessary in this fast moving field of medicine.
Keywords: Immunotherapy, Autoimmune, Cancer immunology, Side effects, Adverse effects

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.